Abstract
It is important to perform clinical trials of antiepileptic drugs (AEDs) in elderly because they differ in many ways from younger people. The response of elderly people to AEDs may not be predictable from studies focused exclusively on younger adults. Major issues of concern include altered absorption and metabolism, as well as the likelihood of interactions with concomitant medications.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 45-48 |
| Number of pages | 4 |
| Journal | Epilepsy Research |
| Volume | 68 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2006 |
Bibliographical note
Funding Information:Supported in part by NIH 2P50NS16308.